Scandinavian ChemoTech AB (publ) (FRA:8V6)

Market Cap	8.66M +112.5%
Revenue (ttm)	1.15M +63.9%
Net Income	-574.78K
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2910
Previous Close	0.2560
Day's Range	0.2910 - 0.2910
52-Week Range	0.0860 - 0.6800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8V6

Financial Performance

In 2025, Scandinavian ChemoTech AB's revenue was 12.29 million, an increase of 87.10% compared to the previous year's 6.57 million. Losses were -8.06 million, -41.27% less than in 2024.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 26, 2026

Data Sources Report a data error